Horizon Therapeutics USA, Inc

Registered Principal Details

Business Or Interest:
Pharmaceutical industry and medicines for rare, autoimmune and severe inflammatory diseases.

Lobbying Interests:
All matters relating to the pharmaceutical industry and medicines for rare, autoimmune and severe inflammatory diseases

CEO Name:
Tim Walbert
Director

Contact
JI
Julie Idelkope
1 Horizon Way
Deerfield, IL 60015
(612) 805-5493
jidelkope@horizontherapeutics.com
https://www.horizontherapeutics.com/

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 744
Assembly Bill 744
Relating to: rare disease advisory council. (FE)

Bill Text and History

For
Notification Date
1/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 689
Senate Bill 689
Relating to: rare disease advisory council. (FE)

Bill Text and History

For
Notification Date
1/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Development, drafting or introduction of a proposal relating to the creation of a Rare Disease Advisory Council.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to the creation of a Rare Disease Advisory Council.

Action Intended To Affect
Both Legislative matter and rule

Notification Date
10/21/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2021
July - December
2022
January - June
Total
Total Lobbying Expenditures 2021
July - December
$15,000.00
2022
January - June
$18,000.00
Total $33,000.00
Total Hours Communicating 2021
July - December
0.00
2022
January - June
3.00
Total 3.00
Total Hours Other 2021
July - December
3.00
2022
January - June
11.50
Total 14.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: rare disease advisory council. (FE)
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
2022
January - June
20 %
2022
July - December
Total 17 %
Relating to: rare disease advisory council. (FE)
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
2022
January - June
70 %
2022
July - December
Total 57 %

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
100 %
2022
January - June
10 %
2022
July - December
Total 25 %

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures